CD8A and neoplasm: The mechanism is that PAM-RT can promote remodeling of the TME in the primary tumor as well as the metastatic site by reducing Tregs, activating macrophages to an inflammatory phenotype, and promoting infiltration of CD8+ CTLs into metastatic tumors.